SNDL Inc
F:VY4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (6.8), the stock would be worth €1.47 (12% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.1 | €1.31 |
0%
|
| 3-Year Average | 6.8 | €1.47 |
+12%
|
| Industry Average | 10.4 | €2.24 |
+71%
|
| Country Average | 11.9 | €2.57 |
+97%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
SNDL Inc
F:VY4
|
344.2m EUR | 6.1 | -34.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 53.6 | 42.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
544.6B USD | 23.1 | 25.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 14.9 | 19.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.8B GBP | 21.9 | 29.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 15.5 | 20 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
278.5B USD | 18.9 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 936 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 10 | 10.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.3B USD | 17.2 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 10.7 | 16.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.9 |
| Median | 11.9 |
| 70th Percentile | 19.5 |
| Max | 22 577.3 |
Other Multiples
SNDL Inc
Glance View
SNDL, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. The company is headquartered in Calgary, Alberta and currently employs 1,346 full-time employees. The company went IPO on 2019-08-01. The company operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. The Liquor Retail segment includes the sale of wines, beers and spirits through wholly owned liquor stores. The Cannabis Retail segment includes the private sale of recreational cannabis through wholly owned and franchise retail cannabis stores. The Cannabis Operations segment include the cultivation, distribution and sale of cannabis for the adult-use market and medical markets in Canada. The Investments segment include the deployment of capital to investment opportunities. The company cannabis brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto, Spiritleaf Selects, Grasslands, Versus Cannabis, Value Buds, Vacay and Grasslands. The company operates over 180 multi-banner cannabis retail store network in Canada.
